Concepedia

Christophe Colas

CC

Statistics

Publications

12

Citations

724

H-Index

12

Active since

1987

Affiliations

University of California, San Francisco(Current)

Vir Biotechnology (Switzerland)

Centre National de la Recherche Scientifique

Rapt Therapeutics (United States)

Université de Strasbourg

Christophe Colas is an author at University of California, San Francisco specializing in pharmacology, biochemistry, and life sciences.

Publications per year

1987–2022

12

Publications

12

The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2

Andrea L. Cathcart, Colin Havenar‐Daughton, Florian A. Lempp et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 254 citations · Full text

, , +14

Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity

Paul R. Leger, Dennis X. Hu, Bérenger Biannic et al. · Journal of Medicinal Chemistry · 2020 · 74 citations · Full text

, , +16

Asp-225 and Glu-375 in Autocatalytic Attachment of the Prosthetic Heme Group of Lactoperoxidase

Christophe Colas, Jane M. Kuo, Paul R. Ortiz de Montellano · Journal of Biological Chemistry · 2002 · 64 citations · Full text

, , +16

An Efficient Procedure for the Synthesis of Crystalline Aryldiazonium Trifluoroacetates – Synthetic Applications

Christophe Colas, Maurice Goeldner · European Journal of Organic Chemistry · 1999 · 60 citations

, , +10

Trp82 and Tyr332 Are Involved in Two Quaternary Ammonium Binding Domains of Human Butyrylcholinesterase as Revealed by Photoaffinity Labeling with [<sup>3</sup>H]DDF

Florian Nachon, Laurence Ehret‐Sabatier, Damarys Loew et al. · Biochemistry · 1998 · 59 citations

, , +12

1–5 of 12